Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.60 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.60 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 6/20 | 0.46 |
| ▸ | PPARD | Q03181 | 6/20 | 0.46 |
| ▸ | PPARA | Q07869 | 6/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5168516 | 1.00 | GPR84 (0.60) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| SCHEMBL15798128 | 0.98 | GPR84 (0.56) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| SCHEMBL8984460 | 0.96 | GPR84 (0.67) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| SCHEMBL8984458 | 0.96 | GPR84 (0.67) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| SCHEMBL8984358 | 0.96 | GPR84 (0.67) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| SCHEMBL8044968 | 0.96 | GPR84 (0.67) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| SCHEMBL8984604 | 0.96 | GPR84 (0.67) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| SCHEMBL8984607 | 0.96 | GPR84 (0.67) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| SCHEMBL8984489 | 0.92 | GPR84 (0.60) | GPR84FFAR1FFAR4CAMK2ATSHR | |
| SCHEMBL4478217 | 0.92 | GPR84 (0.54) | GPR84FFAR1FFAR4TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117860766-A | Composition containing ether type glycerophospholipids and method for producing same | 物心科技株式会社 | 2024-04-12 | — | — | CN | disclosed |
| US-11345690-B2 | Methods of synthesizing a difluorolactam analog | CAYMAN CHEMICAL COMPANY, INC. (US) | 2022-05-31 | — | — | US | disclosed |
| US-20220127252-A9 | METHODS OF SYNTHESIZING A DIFLUOROLACTAM ANALOG | CAYMAN CHEMICAL CO INC (US) | 2022-04-28 | — | — | US | disclosed |
| US-20190202816-A1 | METHODS OF SYNTHESIZING A DIFLUOROLACTAM ANALOG | CAYMAN CHEMICAL CO INC (US) | 2019-07-04 | — | — | US | disclosed |
| US-20190167799-A1 | ETHER TYPE GLYCEROPHOSPHOLIPID-CONTAINING COMPOSITION AND METHOD FOR PRODUCING THE SAME | B&S CORPORATION:KK (JP) | 2019-06-06 | — | — | US | disclosed |
| US-20190133986-A1 | METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION | UNIVERSITY OF WASHINGTON | 2019-05-09 | — | — | US | disclosed |
| EP-2252276-B1 | METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION | UNIV WASHINGTON (US) | 2019-03-27 | — | — | EP | disclosed |
| US-20180170918-A1 | METHODS OF SYNTHESIZING A DIFLUOROLACTAM ANALOG | CAYMAN CHEMICAL CO INC (US) | 2018-06-21 | — | — | US | disclosed |
| US-20180098955-A1 | METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION | UNIVERSITY OF WASHINGTON | 2018-04-12 | — | — | US | disclosed |
| US-9914725-B2 | Methods of synthesizing a difluorolactam analog | CAYMAN CHEMICAL COMPANY, INC. (US) | 2018-03-13 | — | — | US | disclosed |
| US-20030158246-A1 | For the treatment of prostaglandin mediated diseases, such as allergic asthma or rhinitis. | MERCK FROSST CANADA & CO. (CA) | 2003-08-21 | — | — | US | disclosed |
| WO-2003062200-A2 | FLUORO SUBSTITUTED CYCLOALKANOINDOLES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | MERCK FROSST CANADA & CO. (CA) | 2003-07-31 | — | — | WO | disclosed |
| EP-1305286-A2 | CYCLOPENTANOINDOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | MERCK FROSST CANADA INC. (CA) | 2003-05-02 | — | — | EP | disclosed |
| US-6410583-B1 | PROSTAGLANDIN ANTAGONIST | MERCK FROSST CANADA & CO. (CA) | 2002-06-25 | — | — | US | disclosed |
| WO-2002008186-A2 | CYCLOPENTANOINDOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | MERCK FROSST CANADA & CO. (CA) | 2002-01-31 | — | — | WO | disclosed |
| EP-0826684-B1 | PIPERIDINE DERIVATIVES | HISAMITSU PHARMACEUTICAL CO (JP) | 2001-11-21 | — | — | EP | disclosed |
| US-5886011-A | TACHYKININ UNDECAPEPTIDE ANTAGONIST, USEFUL FOR TREATING ASTHMA, OR REMEDY FOR DISEASES ASSOCIATED WITH CENTRAL NERVOUS SYSTEM, DIGESTIVE SYSTEM AND CIRULATORY STYSTEM, AND VARIETY OF PAINS OR INFLAMMATION | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 1999-03-23 | — | — | US | disclosed |
| EP-0826684-A1 | PIPERIDINE DERIVATIVES | Hisamitsu Pharmaceutical Co., Inc. (JP) | 1998-03-04 | — | — | EP | disclosed |
| US-5621140-A | Resolution of ibuprofen | SYNTEX (U.S.A.) INC. (US) | 1997-04-15 | — | — | US | disclosed |
| WO-1996019431-A1 | RESOLUTION OF IBUPROFEN USING A N-ALKYL-D-GLUCAMINE | F. HOFFMANN-LA ROCHE AG (CH) | 1996-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190167799-A1 | ETHER TYPE GLYCEROPHOSPHOLIPID-CONTAINING COMPOSITION AND METHOD FOR PRODUCING THE SAME | PHOSPHO1, DDOST, CDIPT | GPR84 2609/4885FFAR1 2993/4885FFAR4 2343/4885 |
| US-20030158246-A1 | For the treatment of prostaglandin mediated diseases, such as allergic asthma or rhinitis. | PTGES, PTGIR, PTGER1 | GPR84 190/4885FFAR1 108/4885FFAR4 117/4885 |
| US-20190133986-A1 | METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION | ALDH1A2, ALDH1A3, RBP4 | GPR84 604/4885FFAR1 358/4885FFAR4 628/4885 |
| US-20190202816-A1 | METHODS OF SYNTHESIZING A DIFLUOROLACTAM ANALOG | PTGER4, PTGER1, PTGIR | GPR84 21/4885FFAR1 60/4885FFAR4 17/4885 |
| US-11345690-B2 | Methods of synthesizing a difluorolactam analog | PTGER4, PTGER1, PTGIR | GPR84 21/4885FFAR1 60/4885FFAR4 17/4885 |
| US-20180098955-A1 | METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION | ALDH1A2, ALDH1A3, RBP4 | GPR84 604/4885FFAR1 358/4885FFAR4 628/4885 |
| US-20180170918-A1 | METHODS OF SYNTHESIZING A DIFLUOROLACTAM ANALOG | PTGER4, PTGER1, PTGIR | GPR84 21/4885FFAR1 60/4885FFAR4 17/4885 |
| US-20220127252-A9 | METHODS OF SYNTHESIZING A DIFLUOROLACTAM ANALOG | PTGER4, PTGER1, PTGIR | GPR84 21/4885FFAR1 60/4885FFAR4 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.